2024-03-29T02:18:52Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_BA8EC7971B3B
2024-03-23T02:54:07Z
serval:BIB_BA8EC7971B3B
Effectiveness, Adherence, and Safety of Evolocumab in a Swiss Multicenter Prospective Observational Study.
10.1007/s12325-021-01962-w
000720198300001
34796465
Nanchen
D.
author
Carballo
D.
author
Bilz
S.
author
Rickli
H.
author
Koskinas
K.C.
author
Mach
F.
author
Mueller
C.
author
Crljenica
C.
author
Rossi
M.
author
Reichert
N.
author
Sudano
I.
author
article
2022-01
Advances in therapy
1865-8652
0741-238X
journal
39
1
504-517
Adult
Antibodies, Monoclonal, Humanized/therapeutic use
Anticholesteremic Agents/therapeutic use
Atherosclerosis/drug therapy
Cholesterol, LDL/blood
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use
Switzerland
Treatment Outcome
Adherence
Cardiovascular disease
Evolocumab
LDL-C goals
Real-world evidence
Reimbursement
eng
60_published
true
peer-reviewed
Publication types: Journal Article ; Multicenter Study ; Observational Study ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
https://serval.unil.ch/notice/serval:BIB_BA8EC7971B3B
https://serval.unil.ch/resource/serval:BIB_BA8EC7971B3B.P001/REF.pdf
Restricted: indefinite embargo
Creative Commons : Attribution-NonCommercial 4.0 International